drugset / Trial / NCT02816957

Benefits of Nigella Sativa in Children With Beta Thalassemia Major

NCT02816957

Phase 0 Unknown 80 enrolled Tanta University
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluate the therapeutic effects health benefits, and immunological effect of Nigella sativa in children with beta thalassemia major.

Timeline

Start
2016-06
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nigella sativa Traditional medicine (herbal / TCM) 2 g Oral